Cigna CEO David Cordani Purchases ~$1M in Company Stock (CI)
Cigna Group
Subscribe to track CI
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Cigna CEO Purchases ~$1M in Company Stock (CI)
Company: Cigna Group (CI) Form: 4 | Filed: 2025-11-03 Significance: Low
Insider: Cordani David Title: Chairman & CEO | Relationship: Director, Officer
Transaction: • Type: Purchase • Shares: 4,134 • Price: $241.88 • Value: $999,863 • Owned After: 621,872 (total direct & indirect)
Key Insight: The Chairman & CEO made a ~$1M purchase. While a large sum, it represents a negligible fraction (0.0015%) of the company's $66B market cap, classifying it as a low-significance transaction.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Cigna Group (CI)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chairman & CEO, David Cordani, purchased approximately $1 million worth of Cigna stock through a trust.
- Market Impact: The transaction is considered routine and is unlikely to have a material impact on the stock price due to its small size relative to the company's market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | Cigna Group |
| Ticker Symbol | CI |
| CIK | 0001739940 |
| Industry | Hospital & Medical Service Plans |
Insider Information
| Field | Value |
|---|---|
| Name | Cordani David |
| CIK | 0001318751 |
| Title/Position | Chairman & CEO |
| Relationship | Director, Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | P (Purchase) |
| Security Type | Common Stock, $.01 Par Value |
| Shares Involved | 4,134 |
| Price Per Share | $241.8762 |
| Total Value | $999,863.05 |
| Shares Owned After | 157,935 (in this specific trust) |
| Ownership Type | Indirect (By Trust) |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $999,863.05 |
| % of Market Cap | 0.0015% |
| Shares Transacted | 4,134 |
| % of Shares Outstanding | 0.0015% |
| Post-Transaction Ownership (Total) | 621,872 shares (0.23% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a large-cap company with a market capitalization of approximately $66 billion, a $1 million transaction is financially immaterial.
- Ownership Concentration: The purchase slightly increases the CEO's total holdings to 0.23% of all outstanding shares, which is not a significant concentration.
- Transaction Significance: The transaction's value is less than 0.1% of the market cap and the shares involved are less than 0.1% of shares outstanding, firmly placing this in the 'Low' significance category.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is too small relative to Cigna's market capitalization and public float to influence investor sentiment or stock price in a meaningful way.
Volume & Sentiment
- Expected Volume Impact: Negligible. The trade size is a tiny fraction of the stock's typical daily trading volume.
- Sentiment Indicator: Neutral. While an insider purchase is technically a positive signal, its immaterial size in this context renders it neutral.
Additional Context
Transaction Notes
- Special Circumstances: The purchase was made indirectly through a trust. The filing also notes other holdings in a GRAT and 401(k), indicating a structured approach to asset management. Footnote 1 indicates the shares were bought in a price range from $241.876 to $241.97.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
